FS Development Corp II Cl A (FSII)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | FSII | AMGN | BMY | VRTX | GILD |
| Company | FS Development Corp II Cl A | Amgen Inc | Bristol-Myers Squibb Company | Vertex Pharmaceutic | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 10.05 | 290.84 | 58.35 | 454.30 | 89.81 |
| High | 10.16 | 295.48 | 58.92 | 457.54 | 90.49 |
| Low | 9.69 | 288.78 | 57.62 | 449.04 | 89.27 |
| Last | 9.80 | 294.53 | 58.87 | 450.97 | 90.19 |
| Change | -0.20 | +4.63 | +0.64 | +0.60 | +0.43 |
| % Change | -2.00% | +1.60% | +1.10% | +0.13% | +0.48% |
| Volume | 289,100 | 3,053,300 | 7,412,800 | 1,270,300 | 4,545,800 |
| 20-Day Average Volume | 227,795 | 2,995,300 | 12,412,640 | 1,358,315 | 7,469,685 |
| Previous Close | 10.00 | 289.90 | 58.23 | 450.37 | 89.76 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 11.86 | 306.30 | 56.27 | 477.90 | 90.95 |
| 20-Day Raw Stochastic | 2.99% | 36.00% | 76.16% | 7.97% | 32.06% |
| 20-Day Relative Strength | 38.90% | 40.14% | 62.14% | 41.14% | 54.53% |
| Weighted Alpha | -13.88 | +4.16 | +27.94 | +18.28 | +26.90 |
| Today's Opinion | 8% Buy | 40% Sell | 100% Buy | 24% Sell | 80% Buy |
| Previous Opinion | 8% Buy | 40% Sell | 100% Buy | 8% Sell | 80% Buy |
| Last Month's Opinion | 72% Buy | 8% Buy | 88% Buy | 24% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -7.89% since 12/16/21 | +3.85% since 11/15/24 | +4.71% since 11/15/24 | -3.16% since 11/15/24 | +2.02% since 11/15/24 |
| Low | 9.64 on 12/21/21 | 275.56 on 11/19/24 | 55.84 on 11/18/24 | 445.00 on 11/21/24 | 86.08 on 11/19/24 |
| High | 10.86 on 12/21/21 | 295.48 on 11/22/24 | 58.92 on 11/22/24 | 468.88 on 11/18/24 | 90.49 on 11/22/24 |
| 1-Month | |||||
| %Chg | -30.10% since 11/23/21 | -7.86% since 10/22/24 | +11.58% since 10/22/24 | -5.04% since 10/22/24 | +2.30% since 10/22/24 |
| Low | 9.64 on 12/21/21 | 275.56 on 11/19/24 | 51.81 on 10/28/24 | 445.00 on 11/21/24 | 86.08 on 11/19/24 |
| High | 15.00 on 12/01/21 | 328.25 on 11/08/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | -1.90% since 09/23/21 | -9.24% since 08/22/24 | +23.62% since 08/22/24 | -6.03% since 08/22/24 | +18.83% since 08/22/24 |
| Low | 9.64 on 12/21/21 | 275.56 on 11/19/24 | 47.38 on 08/23/24 | 445.00 on 11/21/24 | 75.91 on 08/23/24 |
| High | 15.05 on 11/19/21 | 339.17 on 09/23/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | -0.81% since 06/23/21 | -4.81% since 05/22/24 | +39.04% since 05/22/24 | +0.77% since 05/22/24 | +33.02% since 05/22/24 |
| Low | 9.64 on 12/21/21 | 275.56 on 11/19/24 | 39.35 on 07/05/24 | 435.57 on 05/30/24 | 62.07 on 05/31/24 |
| High | 15.05 on 11/19/21 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 203,125 | 158,319,600 | 119,398,784 | 116,137,848 | 112,400,728 |
| Shares Outstanding, K | 20,727 | 537,533 | 2,028,177 | 257,529 | 1,246,266 |
| Annual Sales | 0 | 28,190,000,000 | 45,006,000,000 | 9,869,200,000 | 27,116,000,000 |
| Annual Net Income | 0 | 6,717,000,000 | 8,025,000,000 | 3,619,600,000 | 5,665,000,000 |
| Last Quarter Sales | 0 | 8,503,000,000 | 11,892,000,000 | 2,771,900,000 | 7,545,000,000 |
| Last Quarter Net Income | -1,220,000 | 2,830,000,000 | 1,211,000,000 | 1,045,400,000 | 1,253,000,000 |
| 60-Month Beta | N/A | 0.60 | 0.44 | 0.39 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 11/12/21 | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 10/16/12 | 10/30/24 | 10/31/24 | 11/04/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.600 on 10/04/24 | N/A | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | 10/04/24 | N/A | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 15.08 | 49.77 | 0.00 | 20.26 |